We improve the quality of life by creating new medicines

RUS | ENG

+7 (495) 925-30-74

About us
Manufacturing
- API & FDF Experimental Producton
- Biotechnological Producton (BioIntegrator)
Portfolio
Business Incubator
News
Contacts

+7 (495) 925-30-74

About us
Manufacturing
- API & FDF Experimental Producton
- Biotechnological Producton (BioIntegrator)
Portfolio
Business Incubator
News
Contacts

+7 (495) 925-30-74

Home >> Gallery >> 2014

2014

VIEW

VIEW

VIEW

VIEW

VIEW

VIEW

VIEW

VIEW

VIEW

VIEW

VIEW

VIEW

VIEW

VIEW

VIEW

COMPANY NEWS

17.06.2021 Avifavir® for the treatment of COVID-19 is rated among Russia’s TOP 100 Inventions

08.06.2021 Leading infectious disease experts in Russia recognized the efficacy of Avifavir®

24.03.2021 Avifavir obtains its first registration in Asia

10.03.2021 Chromis published results of a multi-center open label post-marketing clinical study in 940 COVID-19 patients confirming efficacy of Avifavir at CROI2021

20.11.2020 The international expert community highlights the efficacy and safety of Avifavir in COVID-19 treatment

all news

Copyright © 2021 HTC "Chemrar"